Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • LabCorp completes private placement of senior notes

    Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. Business: Diagnostic Date completed: 2015-01-21 Type: Private placement of senior notes Raised: $2.9 billion Underwriters: BofA Merrill Lynch; Wells Fargo…

    Published on 1/26/2015
  • Minerva Neurosciences completes debt financing

    Minerva Neurosciences Inc. (NASDAQ:NERV), Cambridge, Mass. Business: Neurology Date completed: 2015-01-20 Type: Debt financing Raised: $10 million Investors: Oxford Finance; Silicon Valley Bank Note: Minerva drew down $…

    Published on 1/26/2015
  • NovaBiotics completes venture financing

    NovaBiotics Ltd., Aberdeen, U.K. Business: Infectious, Supply/Service Date completed: 2015-01-20 Type: Venture financing Raised: 5 million ($7.6 million) Investor: Woodford Investment Management

    Published on 1/26/2015
  • Oculus completes follow-on

    Oculus Innovative Sciences Inc. (NASDAQ:OCLS), Petaluma, Calif. Business: Dermatology Date completed: 2015-01-21 Type: Follow-on Raised: $6.3 million Shares: 6.3 million Price: $1 Shares after offering: 14.9 million …

    Published on 1/26/2015
  • Otonomy completes follow-on

    Otonomy Inc. (NASDAQ:OTIC), San Diego, Calif. Business: Other, Drug delivery, Infectious Date completed: 2015-01-22 Type: Follow-on Raised: $74.6 million Shares: 2.6 million Price: $29.25 Shares after offering: 23.7 …

    Published on 1/26/2015
  • Puma Biotechnology completes follow-on

    Puma Biotechnology Inc. (NYSE:PBYI), Los Angeles, Calif. Business: Cancer Date completed: 2015-01-21 Type: Follow-on Raised: $218.5 million Shares: 1.2 million Price: $190 Shares after offering: 31.3 million …

    Published on 1/26/2015
  • Radius Health completes follow-on

    Radius Health Inc. (NASDAQ:RDUS), Cambridge, Mass. Business: Musculoskeletal, Endocrine/Metabolic, Cancer Date completed: 2015-01-22 Type: Follow-on Raised: $147 million Shares: 4 million Price: $36.75 Shares after …

    Published on 1/26/2015
  • RegenxBio completes venture financing

    RegenxBio Inc., Washington, D.C. Business: Gene/Cell therapy Date completed: 2015-01-21 Type: Venture financing Raised: $30 million Investors: Venrock; Brookside Capital; Deerfield Management; Fidelity Biosciences; …

    Published on 1/26/2015
  • Sensorion completes venture financing

    Sensorion S.A.S., Clapiers, France Business: Other Date completed: 2015-01-20 Type: Venture financing Raised: Not disclosed Investors: InnoBio Fund; Inserm Transfert Note: Sensorion said the investors committed up to 4 …

    Published on 1/26/2015
  • Ultimovacs completes venture financing

    Ultimovacs A/S, Oslo, Norway Business: Cancer Date completed: 2015-01-22 Type: Venture financing Raised: NOK45 million ($5.9 million) Investors: Canica; Sundt

    Published on 1/26/2015
  • Verastem completes follow-on

    Verastem Inc. (NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Date completed: 2015-01-22 Type: Follow-on Raised: $47.1 million Shares: 7.3 million Price: $6.50 Shares after offering: 33.1 million Underwriters: …

    Published on 1/26/2015
  • Versartis completes follow-on

    Versartis Inc. (NASDAQ:VSAR), Redwood City, Calif. Business: Endocrine/Metabolic Date completed: 2015-01-21 Type: Follow-on Raised: $75 million Shares: 4.3 million Price: $17.25 Shares after offering: 28.5 million …

    Published on 1/26/2015
  • Vitae completes follow-on

    Vitae Pharmaceuticals Inc. (NASDAQ:VTAE), Fort Washington, Pa. Business: Cardiovascular, Endocrine/Metabolic, Neurology Date completed: 2015-01-23 Type: Follow-on Raised: $35.7 million Shares: 3 million Price: $11.90 …

    Published on 1/26/2015
  • Vivace Therapeutics completes venture financing

    Vivace Therapeutics Inc., Orinda, Calif. Business: Cancer Date completed: 2015-01-20 Type: Venture financing Raised: $5.1 million Investor: Not disclosed Note: The company raised $5.1 million, according to an SEC filing…

    Published on 1/26/2015
  • Zafgen completes follow-on

    Zafgen Inc. (NASDAQ:ZFGN), Cambridge, Mass. Business: Endocrine/Metabolic Date completed: 2015-01-22 Type: Follow-on Raised: $138 million Shares: 3.9 million Price: $35 Shares after offering: 26.6 million Underwriters: …

    Published on 1/26/2015
  • 4SC financial update

    4SC AG (Xetra:VSC), Planegg-Martinsried, Germany Business: Autoimmune, Cancer Date announced: 2015-01-23 Note: 4SC plans to implement a 1-for-5 reverse stock split. Shareholders will vote on the proposal at an annual …

    Published on 1/26/2015
  • Alder financial update

    Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Bothell, Wash. Business: Antibodies, Autoimmune, Cancer Date announced: 2015-01-22 Note: Alder raised $26.6 million through the sale of 900,000 shares to cover the …

    Published on 1/26/2015
  • Endonovo Therapeutics financial update

    Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif. Business: Inflammation, Autoimmune Date announced: 2015-01-21 Note: Endonovo entered into a $3 million equity purchase agreement with Kodiak Capital Group.

    Published on 1/26/2015
  • Genetic Technologies financial update

    Genetic Technologies Ltd. (ASX:GTG; NASDAQ:GENE), Fitzroy, Australia Business: Diagnostic Date announced: 2015-01-21 Note: Genetic Technologies entered into a two-year standby equity agreement with Kentgrove Capital …

    Published on 1/26/2015
  • Gilde financial update

    Gilde, Utrecht, the Netherlands Business: Finance Date announced: 2015-01-21 Note: Gilde Healthcare closed Gilde Healthcare Services II at EUR100 million ($115.8 million). The fund will invest in specialist clinics, …

    Published on 1/26/2015
  • Kindred Biosciences financial update

    Kindred Biosciences Inc. (NASDAQ:KIN), Burlingame, Calif. Business: Veterinary Date announced: 2015-01-16 Note: Kindred Biosciences filed a shelf registration covering the sale of up to $150 million of its securities. …

    Published on 1/26/2015
  • Plandai financial update

    Plandai Biotechnology Inc. (OTCQB:PLPL), Seattle, Wash. Business: Agbio/Environmental Date announced: 2015-01-21 Note: Plandai filed a shelf registration covering the sale of up to $25 million of its common stock. The …

    Published on 1/26/2015
  • Cantargia proposes IPO

    Cantargia AB, Lund, Sweden Business: Cancer Date announced: 2015-01-16 Type: IPO To be raised: Up to SEK44.1 million ($5.4 million) Shares: 5.8 million Price: SEK7.60 Note: Cantargia plans to list its shares on the …

    Published on 1/26/2015
  • Great Basin proposes private placement of units

    Great Basin Corp. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic Date announced: 2015-01-20 Type: Private placement of units To be raised: Up to $10 million Units: TBD Price prior: $2.63 Shares outstanding …

    Published on 1/26/2015
  • Syndax withdraws IPO

    Syndax Pharmaceuticals Inc., Waltham, Mass. Business: Cancer Date announced: 2015-01-22 Type: IPO Underwriters: Deutsche Bank; Jefferies; JMP Securities; Wedbush Note: Syndax withdrew its IPO on NASDAQ.

    Published on 1/26/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993